We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · July 09, 2020

Association of Bempedoic Acid Administration With Atherogenic Lipid Levels

JAMA Cardiology

 

Additional Info

JAMA Cardiology
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
JAMA Cardiol 2020 Jul 01;[EPub Ahead of Print], M Banach, PB Duell, AM Gotto, U Laufs, LA Leiter, GBJ Mancini, KK Ray, J Flaim, Z Ye, AL Catapano

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading